{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:52:27Z","timestamp":1790617947411,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.urology.2020.08.072","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T01:19:03Z","timestamp":1602292743000},"page":"109-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020"],"prefix":"10.1016","volume":"147","author":[{"given":"Jan Alberto","family":"Paredes Mogica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise J.B.","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.08.072_bib0001","doi-asserted-by":"crossref","first-page":"55\u201062","DOI":"10.1007\/BF02614221","article-title":"Phase I trial of pentosan polysulfate","volume":"13","author":"Swain","year":"1995","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.urology.2020.08.072_bib0002","first-page":"159","article-title":"Un nouvel anticoagulant de synth\u00e8se le thrombocid [Thrombocid: a new synthetic anticoagulant]","volume":"59","author":"Frileux","year":"1951","journal-title":"Presse Med"},{"key":"10.1016\/j.urology.2020.08.072_bib0003","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/BF01490174","article-title":"Beitrag zur Wirkungsweise des Anticoagulans Thrombocid [On the mode of action of thrombocid]","volume":"29","author":"Koncz","year":"1951","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.urology.2020.08.072_bib0004","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/03007995.2019.1586401","article-title":"Efficacy of pentosan polysulfate for the treatment of interstitial cystitis\/bladder pain syndrome: results of a systematic review of randomized controlled trials","volume":"35","author":"van Ophoven","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.urology.2020.08.072_bib0005","doi-asserted-by":"crossref","first-page":"654\u2010658","DOI":"10.1016\/j.urology.2004.10.071","article-title":"Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis","volume":"65","author":"Nickel","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.08.072_bib0006","doi-asserted-by":"crossref","first-page":"939\u2010944","DOI":"10.1093\/oxfordjournals.annonc.a010797","article-title":"A phase I study of pentosan polysulfate sodium in patients with advanced malignancies","volume":"7","author":"Lush","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2020.08.072_bib0007","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0090-4295(97)00714-0","article-title":"Long-term experience with pentosan polysulfate in interstitial cystitis","volume":"51","author":"Jepsen","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.08.072_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0090-4295(97)00179-9","article-title":"Analysis of long-term Elmiron therapy for interstitial cystitis","volume":"49","author":"Hanno","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.08.072_bib0009","doi-asserted-by":"crossref","first-page":"1793\u20101802","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.urology.2020.08.072_bib0010","first-page":"1275\u20101282","article-title":"Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study [published online ahead of print, 2019 Sep 5]","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.urology.2020.08.072_bib0011","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2018.12.037","article-title":"Re: Pearce et al.: Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018;125:1793-1802)","volume":"126","author":"Greenlee","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.urology.2020.08.072_bib0012","doi-asserted-by":"crossref","first-page":"535\u2010543","DOI":"10.1016\/j.ophtha.2019.10.036","article-title":"Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States","volume":"127","author":"Ludwig","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.urology.2020.08.072_bib0013","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort [published online ahead of print, 2019 Nov 6]","author":"Jain","year":"2019","journal-title":"Br J Ophthalmology"},{"key":"10.1016\/j.urology.2020.08.072_bib0014","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.urology.2020.08.072_bib0015","article-title":"A case of pentosan polysulfate maculopathy originally diagnosed as stargardt disease","volume":"17","author":"Vora","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.urology.2020.08.072_bib0016","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.oret.2019.08.006","article-title":"Choroidal Neovascularization associated with pentosan polysulfate toxicity","volume":"4","author":"Mishra","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.urology.2020.08.072_bib0017","article-title":"Retinal toxicity in a patient on pentosan polysulfate sodium [published online ahead of print, 2020 Apr 17]","author":"Wingelaar","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.08.072_bib0018","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3928\/23258160-20191009-10","article-title":"Progressive maculopathy after discontinuation of pentosan polysulfate sodium","volume":"50","author":"Huckfeldt","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.urology.2020.08.072_bib0019","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ophtha.2019.10.013","article-title":"A novel multimethod image analysis to quantify pentosan polysulfate sodium retinal toxicity","volume":"127","author":"Hadad","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.urology.2020.08.072_bib0020","first-page":"45","article-title":"MP47-03 - Chronic exposure to pentosan polysulfate sodium is associated with retinal pigmentary changes and vision loss","volume":"201","author":"Foote","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.08.072_bib0021","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.urology.2020.08.072_bib0022","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.urology.2020.08.072_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2020.05.008","article-title":"Pentosan polysulfate maculopathy versus inherited macular dystrophies: comparative assessment with multimodal imaging [published online ahead of print, 2020 May 21]","author":"Barnes","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.urology.2020.08.072_bib0024","unstructured":"Optum Clinformatics Data Mart Database. Available at: https:\/\/web.uri.edu\/optum\/ Accessed June 30, 2020"},{"key":"10.1016\/j.urology.2020.08.072_bib0025","unstructured":"IBM MarketScan Research Databases. Available at:https:\/\/www.ibm.com\/products\/marketscan-research-databases Accessed June 30, 2020"},{"key":"10.1016\/j.urology.2020.08.072_bib0026","first-page":"e109ee114","article-title":"Research techniques made simple: assessing risk of bias in systematic reviews","volume":"136","author":"Drucker1","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.urology.2020.08.072_bib0027","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.urology.2020.08.072_bib0028","unstructured":"GA Wells, B Shea, D O'Connell, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa Hospital Research Institute. Available at: http:\/\/www.ohri.ca\/home.asp. Accessed June 6, 2020."},{"issue":"5A Suppl","key":"10.1016\/j.urology.2020.08.072_bib0029","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(99)80327-6","article-title":"Epidemiology of interstitial cystitis","volume":"49","author":"Jones","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.08.072_bib0030","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","article-title":"Pentosan polysulfate sodium for treatment of interstitial cystitis\/bladder pain syndrome: insights from a randomized, double-blind, placebo-controlled study","volume":"193","author":"Nickel","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.08.072_bib0031","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamaophthalmol.2020.2349","article-title":"Disease course in patients with pentosan polysulfate sodium-associated maculopathy after drug cessation","volume":"138","author":"Shah","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.urology.2020.08.072_bib0032","series-title":"Elmiron (Pentosan Polysulfate sodium)","year":"2020"},{"key":"10.1016\/j.urology.2020.08.072_bib0033","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5489\/cuaj.6401","article-title":"Possible drug-induced, vision-threatening maculopathy secondary to chronic pentosan polysulfate sodium (Elmiron\u00ae) exposure","volume":"14","author":"Doiron","year":"2020","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urology.2020.08.072_bib0034","series-title":"Elmiron (Pentosan Polysulfate Sodium) [Product Monograph]","year":"2019"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520312401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520312401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:15:52Z","timestamp":1758766552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520312401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":34,"alternative-id":["S0090429520312401"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.08.072","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.08.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}